![]() |
|||||||||||||||||
![]() |
|||||||||||||||||
![]() ![]() ![]() |
![]() |
|
|||||||||||||||
![]() |
![]() |
MATERIAL SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS AGENT NAME: Adenovirus types 40 and 41 SYNONYM OR CROSS REFERENCE: Adv 40, Adv 41, Mastadenovirus h40, Mastadenovirus h41, subgenus F, enteric adenovirus CHARACTERISTICS: Adenoviridae; double-stranded, linear DNA genome, 70-90 nm diameter, non-enveloped, icosahedral SECTION II - HEALTH HAZARD PATHOGENICITY: Local replication in intestine causes a mild disease with clinical symptoms of nausea, vomiting, diarrhea, malaise; virus show restricted replication; tissues of the eye and respiratory tract; asymptomatic infection common (virus in faeces of healthy individuals) EPIDEMIOLOGY: Worldwide; in outbreaks and sporadic cases; cause severe cases in infants and young children; infections occur throughout the year with no clear peaks HOST RANGE: Humans; experimentally infected rabbits, pigs and calves INFECTIOUS DOSE: Unknown MODE OF TRANSMISSION: presumably person-to-person by the fecal-oral route; respiratory route INCUBATION PERIOD: 3 to 10 days COMMUNICABILITY: During acute stage of disease; healthy adults may be carriers SECTION III - DISSEMINATION RESERVOIR: Humans ZOONOSIS: None VECTORS: None SECTION IV - VIABILITY DRUG SUSCEPTIBILITY: Not applicable SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to 1% sodium hypochlorite, glutaraldehyde, formaldehyde; some non-lipid viruses are only moderately resistant to disinfectants, i.e. 70% ethanol PHYSICAL INACTIVATION: Susceptible to heat (56°C for at least 30 min); infectivity sensitive to ionizing radiation; stable to lipid solvents SURVIVAL OUTSIDE HOST: Stable for some time in the environment SECTION V - MEDICAL SURVEILLANCE: Watch for symptoms of respiratory or gastrointestinal illness FIRST AID/TREATMENT: Electrolyte and fluid replacement in severe cases IMMUNIZATION: None available PROPHYLAXIS: Not available SECTION VI - LABORATORY HAZARDS LABORATORY-ACQUIRED INFECTIONS: Low potential infection risk to laboratory personnel; 10 reported cases up to 1974 SOURCES/SPECIMENS: Nasopharageal secretions, eye exudates, fecal specimens, urine specimens PRIMARY HAZARDS: Ingestion; accidental parenteral inoculation; droplet exposure of the mucous membranes of the eyes, nose, or mouth; inhalation of concentrated aerosolized material SPECIAL HAZARDS: None SECTION VII - RECOMMENDED PRECAUTIONS CONTAINMENT REQUIREMENTS: Biosafety level 2 practices, containment equipment and facilities for activities utilizing known or potentially infectious clinical materials or cultures PROTECTIVE CLOTHING: Laboratory coat; gloves when direct contact with infectious materials is unavoidable OTHER PRECAUTIONS: Procedures that are likely to generate aerosols should be conducted in a biosafety cabinet SECTION VIII - HANDLING INFORMATION SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with an absorbent material (paper towel) and then apply 1% sodium hypochlorite, starting at the perimeter and working towards the centre; allow sufficient contact time (30 min) before clean up DISPOSAL: Decontaminate before disposal - steam sterilization, incineration, chemical disinfection STORAGE: In sealed containers with appropriate labelling SECTION IX - MISCELLANEOUS INFORMATION Date prepared: November 1999 Prepared by: Office of Laboratory Security, PHAC Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date. Copyright © [Material Safety Data Sheets - Index]
|
![]() |
|||
![]() |
Last Updated: 2001-01-23 | ![]() |